Knowledge and attitude regarding human papillomavirus vaccine and its associated factors among parents of daughters age between 9-14 years in central Ethiopia, 2021

Author:

Humnesa Haroma,Aboma MechaORCID,Dida NagasORCID,Abebe MitsiwatORCID

Abstract

Background. Human Papillomavirus (HPV) is the most common sexually transmitted disease and the major cause of cervical cancer, which threatened the lives of several women and remains a critical concern in Africa and around the world. Ethiopia initiates the human papillomavirus vaccines on 3rd December 2018 for the primary time to vaccinate six million girls. Objective. This study assessed knowledge and attitudes toward the human papillomavirus vaccine among parents of daughters aged between 9 and 14 years in the Central Ethiopia Methods. A community-based cross-sectional study was conducted on 619 parents whose daughters were aged between 9 and 14 years old from February 01 to February 30, 2021. A multistage sampling method was employed to select study participants. Data were collected using an interview administered questionnaire adapted from related literature. Descriptive, bivariate, and multivariate binary logistic regression analyses were done by using SPSS v. 20.0. Results. A total of 619 parents participated in the current study of whom, only 242 (39.1%) and 249 (40.2%) of the respondents were knowledgeable and had a favorable attitude toward the HPV, respectively. Age (AOR 1.98, 95% CI: 1.07, 3.69), place of residence (AOR 3.6, 95% CI: 1.45, 8.92), and wealth status (AOR 1.89, 95% CI: 1.09, 3.26) was independently associated with the knowledge of parents toward the HPV. Conclusion. Policymakers and other stockholders require more effort to provide a resource to enhance knowledge and attitudes toward the HPV through the mass media and other health education outlets.

Publisher

PAGEPress Publications

Subject

Public Health, Environmental and Occupational Health

Reference38 articles.

1. Mondiale dela Santé O, Organization WH. Human papillomavirus vaccines: WHO position paper, 2017–Vaccins contreles papillomavirus humains: note de synthèse del’OMS, mai 2017. Weekly Epidemiological Record Relevé épidémiologique hebdomadaire. 2017; 92(19):241-68.

2. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012; 30:F12-F23.

3. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre) of Ethiopia. Human Papillomavirus and Related Diseases Report in Ethiopia, 2019.

4. Turiho AK, Okello, E. S., Muhwezi, W. W, Harvey, S., ByakikaKibwika, P, Meya, D. & Katahoire, A.R. Effect of school-based Human Papillomavirus vaccination on daughters girls’ knowledge and acceptability of the HPV vaccine in Ibanda in Uganda. African Journal of Reproductive Health, 2014.

5. Ramogola-Masire D. HPV vaccine for cervical cancer prevention in Botswana. Commonwealth Health Partnerships, 2014.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3